Correlation Between Aravive and Scpharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Aravive and Scpharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aravive and Scpharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aravive and Scpharmaceuticals, you can compare the effects of market volatilities on Aravive and Scpharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aravive with a short position of Scpharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aravive and Scpharmaceuticals.
Diversification Opportunities for Aravive and Scpharmaceuticals
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Aravive and Scpharmaceuticals is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Aravive and Scpharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scpharmaceuticals and Aravive is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aravive are associated (or correlated) with Scpharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scpharmaceuticals has no effect on the direction of Aravive i.e., Aravive and Scpharmaceuticals go up and down completely randomly.
Pair Corralation between Aravive and Scpharmaceuticals
Given the investment horizon of 90 days Aravive is expected to under-perform the Scpharmaceuticals. In addition to that, Aravive is 1.27 times more volatile than Scpharmaceuticals. It trades about -0.83 of its total potential returns per unit of risk. Scpharmaceuticals is currently generating about -0.04 per unit of volatility. If you would invest 846.00 in Scpharmaceuticals on September 12, 2024 and sell it today you would lose (485.00) from holding Scpharmaceuticals or give up 57.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 1.14% |
| Values | Daily Returns |
Aravive vs. Scpharmaceuticals
Performance |
| Timeline |
| Aravive |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Scpharmaceuticals |
Aravive and Scpharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aravive and Scpharmaceuticals
The main advantage of trading using opposite Aravive and Scpharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aravive position performs unexpectedly, Scpharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scpharmaceuticals will offset losses from the drop in Scpharmaceuticals' long position.The idea behind Aravive and Scpharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Transaction History View history of all your transactions and understand their impact on performance |